Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.650.600.620.600.64

What is the latest Fixed Capital/Sales ratio of EMCURE PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of EMCURE PHARMACEUTICALS is 0.65 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.65
Mar20230.60
Mar20220.62
Mar20210.60
Mar20200.64

How is Fixed Capital/Sales of EMCURE PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.65
8.33
Mar2023 0.6
-3.23
Mar2022 0.62
3.33
Mar2021 0.6
-6.25
Mar2020 0.64 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹18,700.8 Cr -8% 4.7% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,142.0 Cr -1.5% 9.1% 9.1% Stock Analytics
DIVIS LABORATORIES ₹145,762.0 Cr -4.9% -0.6% 59.1% Stock Analytics
CIPLA ₹114,322.0 Cr -1.8% 1% 0.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,171.0 Cr 1.6% 12.1% 21.8% Stock Analytics
DR REDDYS LABORATORIES ₹92,603.7 Cr -3% -0.9% -7.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-8%

4.7%

NA
SENSEX

-2.9%

3.1%

1.8%


You may also like the below Video Courses